U

SciTech Development

Introducing Our Lead Cancer Drug Candidate ST-001 nanoFenretinide and New Drug Delivery Platform.
Multinational United States
Last Update Dec 27, 2024

SciTech Development Business

Business models
Product stage
Employees

Sector

Target Customer

Core Technology